210 related articles for article (PubMed ID: 22895538)
1. Alteration in E-cadherin/β-catenin expression in canine melanotic tumors.
Han JI; Kim Y; Kim DY; Na KJ
Vet Pathol; 2013 Mar; 50(2):274-80. PubMed ID: 22895538
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of the Wnt/beta-catenin signaling pathway in canine cutaneous melanotic tumor.
Han JI; Kim DY; Na KJ
Vet Pathol; 2010 Mar; 47(2):285-91. PubMed ID: 20139375
[TBL] [Abstract][Full Text] [Related]
3. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
4. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors.
Brunetti B; Sarli G; Preziosi R; Monari I; Benazzi C
Vet Pathol; 2005 Nov; 42(6):781-7. PubMed ID: 16301574
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin and beta-catenin expression patterns in malignant melanoma assessed by image analysis.
Pećina-Slaus N; Zigmund M; Kusec V; Martić TN; Cacić M; Slaus M
J Cutan Pathol; 2007 Mar; 34(3):239-46. PubMed ID: 17302608
[TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Sharma A; Chosdol K; Kashyap S; Rai A; Pushker N; Bajaj MS; Ghose S
Br J Dermatol; 2012 Sep; 167(3):583-90. PubMed ID: 22458737
[TBL] [Abstract][Full Text] [Related]
9. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin and β-catenin expression in canine colorectal adenocarcinoma.
Aresu L; Pregel P; Zanetti R; Caliari D; Biolatti B; Castagnaro M
Res Vet Sci; 2010 Dec; 89(3):409-14. PubMed ID: 20457460
[TBL] [Abstract][Full Text] [Related]
11. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K
Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
13. C-kit expression in canine mucosal melanomas.
Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK
Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314
[TBL] [Abstract][Full Text] [Related]
14. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
15. ZEB and Snail expression indicates epithelial-mesenchymal transition in canine melanoma.
Veloso ES; Gonçalves INN; Silveira TL; Espirito Santo JT; Figueiredo LV; Varaschin MS; Cassali GD; Del Puerto HL; Ferreira E
Res Vet Sci; 2020 Aug; 131():7-14. PubMed ID: 32278962
[TBL] [Abstract][Full Text] [Related]
16. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin/catenin complex status in solid pseudopapillary tumor of the pancreas.
El-Bahrawy MA; Rowan A; Horncastle D; Tomlinson I; Theis BA; Russell RC; Stamp G
Am J Surg Pathol; 2008 Jan; 32(1):1-7. PubMed ID: 18162763
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
[TBL] [Abstract][Full Text] [Related]
19. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.
Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Uchida K; Kadosawa T; Taniyama H
Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700
[TBL] [Abstract][Full Text] [Related]
20. Expression of monocarboxylate transporter 1 in oral and ocular canine melanocytic tumors.
Shimoyama Y; Akihara Y; Kirat D; Iwano H; Hirayama K; Kagawa Y; Ohmachi T; Matsuda K; Okamoto M; Kadosawa T; Yokota H; Taniyama H
Vet Pathol; 2007 Jul; 44(4):449-57. PubMed ID: 17606506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]